menu search

Arbutus biopharma: how will patent win impact stock outlook?

Arbutus Biopharma Corporation is a clinical-stage biopharmaceutical company with research specializatio...

December 17, 2021, 1:08 pm

Arbutus biopharma: how will patent win impact stock outlook?

Arbutus Biopharma Corporation is a clinical-stage biopharmaceutical company with research specializatio...

December 17, 2021, 1:08 pm

Arbutus biopharma: how will patent win impact stock outlook?

Arbutus Biopharma Corporation is a clinical-stage biopharmaceutical company with research specializatio...

December 17, 2021, 1:08 pm

Pfizer requests full approval for covid-19 vaccine for 12- to 15-year-olds

The pharmaceutical company said in November its vaccine gave the age group 100% long-term protection ag...

December 16, 2021, 8:43 pm

Pfizer requests full approval for covid-19 vaccine for 12- to 15-year-olds

The pharmaceutical company said in November its vaccine gave the age group 100% long-term protection ag...

December 16, 2021, 8:43 pm

Pfizer requests full approval for covid-19 vaccine for 12- to 15-year-olds

The pharmaceutical company said in November its vaccine gave the age group 100% long-term protection ag...

December 16, 2021, 8:43 pm

Endo: fda approves generic form of vasostrict creating headwind into next year

Eagle pharmaceuticals receives FDA approval to sell a generic form of vasopressin, a competitor to ENDP...

December 16, 2021, 1:24 pm

Endo: fda approves generic form of vasostrict creating headwind into next year

Eagle pharmaceuticals receives FDA approval to sell a generic form of vasopressin, a competitor to ENDP...

December 16, 2021, 1:24 pm

Endo: fda approves generic form of vasostrict creating headwind into next year

Eagle pharmaceuticals receives FDA approval to sell a generic form of vasopressin, a competitor to ENDP...

December 16, 2021, 1:24 pm

Abivax: potentially the next arena pharmaceuticals, most ideal big pharma m&a target in 2022

Arena pharmaceuticals got acquired by Pfizer for US$ 6.7 Bn (~100% valuation) on December 12th. As a re...

December 15, 2021, 10:13 pm

Abivax: potentially the next arena pharmaceuticals, most ideal big pharma m&a target in 2022

Arena pharmaceuticals got acquired by Pfizer for US$ 6.7 Bn (~100% valuation) on December 12th. As a re...

December 15, 2021, 10:13 pm

Abivax: potentially the next arena pharmaceuticals, most ideal big pharma m&a target in 2022

Arena pharmaceuticals got acquired by Pfizer for US$ 6.7 Bn (~100% valuation) on December 12th. As a re...

December 15, 2021, 10:13 pm

Pfizer stock heads toward record after $6.7 billion takeover of arena; deal ‘makes strategic sense to us,' says analyst

Pfizer Inc. said Monday it has agreed to acquire Arena pharmaceuticals Inc. in a deal with a value of a...

December 13, 2021, 1:18 pm

Pfizer stock heads toward record after $6.7 billion takeover of arena; deal ‘makes strategic sense to us,' says analyst

Pfizer Inc. said Monday it has agreed to acquire Arena pharmaceuticals Inc. in a deal with a value of a...

December 13, 2021, 1:18 pm

Pfizer stock heads toward record after $6.7 billion takeover of arena; deal ‘makes strategic sense to us,' says analyst

Pfizer Inc. said Monday it has agreed to acquire Arena pharmaceuticals Inc. in a deal with a value of a...

December 13, 2021, 1:18 pm

Regeneron stock (regn): $824 price target from goldman sachs

The shares of Regeneron pharmaceuticals Inc (NASDAQ: REGN) have received an $824 price target from Gold...

December 12, 2021, 10:34 am

Regeneron stock (regn): $824 price target from goldman sachs

The shares of Regeneron pharmaceuticals Inc (NASDAQ: REGN) have received an $824 price target from Gold...

December 12, 2021, 10:34 am

Regeneron stock (regn): $824 price target from goldman sachs

The shares of Regeneron pharmaceuticals Inc (NASDAQ: REGN) have received an $824 price target from Gold...

December 12, 2021, 10:34 am

Novartis sees strong interest in sandoz generics unit - finanz und wirtschaft

Novartis is seeing strong interest from private equity investors as well as from other pharmaceuticals ...

December 11, 2021, 8:40 am

Novartis sees strong interest in sandoz generics unit - finanz und wirtschaft

Novartis is seeing strong interest from private equity investors as well as from other pharmaceuticals ...

December 11, 2021, 8:40 am


Search within

Pages Search Results: